Skip to content

Follow your curiosity.

Try “brain”, “genomics”, or another subject you follow.

Digital Health · The big question

New AI Tool Matches Human Experts in Planning Prostate MRI Scans

Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes.

Editorial illustration for Deep learning-based automatic field of view planning for prostate MRI in oblique coronal and oblique axial planes.
Editorial illustration

Summary

When a patient undergoes an MRI scan to check for prostate cancer, a medical professional must carefully line up the machine to capture the exact right area. This process, known as field of view planning, is especially tricky for prostate imaging because the gland needs to be viewed from complex, angled perspectives. As a result, the quality of the scan heavily depends on the individual skill of the operator, leading to variations in how the images turn out.

To solve this problem of inconsistency, researchers developed an artificial intelligence tool to automate the scanner setup. They used a deep learning framework, a type of computer algorithm highly skilled at recognizing patterns in images, and trained it on nearly 1,500 past prostate MRI exams. The team then tested the AI on over 500 new exams from different hospitals to see if it could correctly position the digital image slices without human help.

The results showed that the AI matched the performance of human experts. The automated field of view predictions overlapped with the ideal manual setups by up to 88 percent, and the scanning angles were off by an average of less than five degrees. When clinical experts reviewed the AI's automated setups across different hospitals, they accepted them between 95 and 100 percent of the time, proving the tool is highly accurate.

Why it matters.

Consistency in MRI scans is vital for accurately diagnosing and monitoring prostate cancer. By handing the complex scanner setup over to artificial intelligence, hospitals could ensure every patient gets a high-quality scan regardless of the technician's experience level or the clinic's location. This kind of automation could also speed up the scanning process, reducing wait times for patients and lowering costs for healthcare systems.

While these results are highly promising, the technology is not quite ready for everyday hospital use. The researchers note that this study evaluated the AI using past medical records. The next critical step will be to test the software in real time with actual patients to confirm it works safely and smoothly in an active, fast-paced clinical setting.

From the source

The story in numbers.

Training examinations
1,474
External validation examinations
530
Clinical acceptability rate range
95.7% - 100%
Keep the context

Follow the evidence.

This AI-assisted summary is a starting point. Read the original reporting for its methods, scope, and limitations.

Your next discovery.

Keep exploring ↗
Digital Health

Upgraded medical AI can now request and analyze diverse diagnostic data.

Imagine chatting with a computer program that not only understands your symptoms but can also act like a medical detective. Researchers have developed a specialized artificial intelligence called the Articulate Medical Intelligence Explorer, or AMIE. This system is a large language model, which is a type of AI trained on vast amounts of text to understand and generate human language. Unlike general conversational programs, AMIE is custom-built specifically to hold diagnostic conversations with patients. Recent upgrades have given AMIE a powerful new set of skills. The AI can now handle multimodal medical data, meaning it can process different kinds of information at the same time. Instead of just passively receiving a list of symptoms, the upgraded system can actively ask for specific medical data, interpret those results, and use that combined information to logically think through a potential diagnosis.

Nature Medicine1 min read
Digital Health

New AI Tool Uses Retinal Scans to Detect Multiple Diseases

Researchers have developed a new artificial intelligence system designed to detect multiple diseases just by analyzing images of the eye. Known as Reti-Pioneer, this computer program examines scans of the retina, the light-sensitive tissue at the back of the eye. By reviewing these pictures, the AI can check for signs of several different health conditions all at once. To build this tool, the research team trained the AI using a massive collection of eye images gathered from various healthcare centers, ranging from local community clinics to large, specialized hospitals. This broad mix of data helps ensure the program works well for different types of patients. The creators then tested the system using outside data, confirming that it performs reliably beyond the original images it was trained on. The system has already been put to the test in real healthcare settings. Through an initial pilot study and a silent trial, where the AI ran in the background without affecting patient care, researchers showed that the tool is fast and practical for doctors to use. However, the study does not yet specify exactly which diseases the AI targets, the exact number of patients tested, or the precise accuracy rates of the diagnoses.

Nature Medicine1 min read
Digital Health

Supreme Court Preserves Telehealth Access to Mifepristone for Now

The Supreme Court has decided that mifepristone, a key medication used in medical abortions, can still be prescribed through telehealth and delivered by mail for the time being. This decision reverses a recent ruling by the 5th Circuit Court of Appeals, which had attempted to temporarily block doctors from prescribing the medication remotely. The legal dispute centers on safety protocols known as Risk Evaluation and Mitigation Strategies. Originally, these rules required patients to obtain mifepristone in person, but the Food and Drug Administration lifted those specific restrictions in 2021 to allow remote prescribing. The state of Louisiana is currently challenging this change in court, arguing that allowing doctors to prescribe the drug via telehealth directly undermines the state's strict abortion ban. It is important to note that the current Supreme Court decision is only a temporary measure. The broader case will continue to move its way through the justice system, meaning the ultimate legality of telehealth distribution for mifepristone remains highly uncertain.

STAT News1 min read

A little science goes a long way.

Clear, thoughtful biotech briefings. In your inbox three times a week.

Stay curious. Subscribe free ↗
New AI Tool Matches Human Experts in Planning Prostate MRI Scans — Daily Strand